The CEO will lead the company's strategic growth, including fundraising, indication prioritization, and team building. They will oversee the transition of the lead drug candidate from preclinical development through to clinical trials.
The CEO will lead all aspects of the venture's growth, from setting strategy to advancing its first programs into clinical trials. This role requires a combination of scientific understanding and strong business and fundraising skills.